This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Oct;46(8):769-770.

doi: 10.1111/apt.14266.

Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed

R Huang¹, J Wang², J Xia¹, X Yan¹, C Wu¹

Affiliations

Affiliations

¹ Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Jiangsu, China.
² Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Jiangsu, China.

PMID: 28901572
DOI: 10.1111/apt.14266

Comment

Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed

R Huang et al. Aliment Pharmacol Ther. 2017 Oct.

. 2017 Oct;46(8):769-770.

doi: 10.1111/apt.14266.

Authors

R Huang¹, J Wang², J Xia¹, X Yan¹, C Wu¹

Affiliations

¹ Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Jiangsu, China.
² Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Jiangsu, China.

PMID: 28901572
DOI: 10.1111/apt.14266

No abstract available

PubMed Disclaimer

Comment in

Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' reply.
Shaheen AA, Al-Mattooq M, Yazdanfar S, Burak KW, Swain MG, Congly SE, Borman MA, Lee SS, Myers RP, Coffin CS. Shaheen AA, et al. Aliment Pharmacol Ther. 2017 Oct;46(8):770-771. doi: 10.1111/apt.14282. Aliment Pharmacol Ther. 2017. PMID: 28901569 No abstract available.

Comment on

Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers.
Shaheen AA, AlMattooq M, Yazdanfar S, Burak KW, Swain MG, Congly SE, Borman MA, Lee SS, Myers RP, Coffin CS. Shaheen AA, et al. Aliment Pharmacol Ther. 2017 Sep;46(6):599-604. doi: 10.1111/apt.14218. Epub 2017 Jul 13. Aliment Pharmacol Ther. 2017. PMID: 28707319

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations